Sal Rico
About Sal Rico
Sal Rico is the Chief Medical Officer with a strong background in pharmacology and clinical development, known for leading the development of gene therapies and contributing to the regulatory approval of various medical products.
Sal Rico Chief Medical Officer
Sal Rico currently holds the position of Chief Medical Officer. With a robust background in medicine and pharmacology, Rico oversees the medical and clinical strategies within the organization. His role involves guiding clinical teams, developing medical insights, and ensuring that clinical practices align with regulatory standards.
Sal Rico Education
Sal Rico holds a Doctor of Medicine and Surgery degree from the National Autonomous University of Mexico. Additionally, he has earned both an M.S. and a Ph.D. in pharmacology from the Universitat Autonoma de Barcelona. His advanced degrees underpin his expertise in medical sciences and pharmacological research.
Sal Rico Professional Background
Prior to his current role, Sal Rico served as senior vice president of clinical development at Audentes Therapeutics. In this capacity, he spearheaded various clinical initiatives, working at the forefront of gene therapy research, particularly focusing on the development of resamirigene bilparvovec, an AAV-based gene therapy for X-linked myotubular myopathy. His extensive experience also includes working on the design, conduct, and analysis of Phase I-IV clinical trials across numerous therapeutic areas.
Sal Rico Clinical Development Experience
During his tenure in clinical development, Sal Rico led the clinical strategy for resamirigene bilparvovec, targeting X-linked myotubular myopathy. His involvement in the clinical stages comprised the comprehensive design, accurate conduct, and thorough analysis of various Phase I-IV clinical trials. Rico's experience spans multiple therapeutic areas, enhancing his capability to contribute significantly to the clinical research and development sector.
Sal Rico Contributions to Drug Regulatory Approval
Sal Rico has played a vital role in the regulatory approval of several drugs, biological products, and medical devices. His extensive knowledge and experience in clinical development have been crucial in navigating the regulatory pathways, ensuring compliance with health authorities, and facilitating the advancement of medical innovations to market.